Polypid Ltd. (PYPD) SEC Filings — 2024
25 SEC filings for Polypid Ltd. (PYPD) in 2024.
Filings
- PolyPid Ltd. Secures Private Placement Funding — 6-K · Dec 26, 2024
- Polypid Ltd. SC 13G/A Filing — SC 13G/A · Dec 12, 2024
- PolyPid & ImmunoGenesis Partner for Cancer Immunotherapy — 6-K · Dec 11, 2024
- PolyPid Gets Nasdaq Delisting Warning for Equity — 6-K · Nov 29, 2024
- PolyPid Ltd. Reports Q3 2024 Financials and Corporate Update — 6-K · Nov 13, 2024
- PolyPid Ltd. to Sell Up to $8.25M in Shares — 6-K · Nov 8, 2024
- Polypid Ltd. SC 13G/A Filing — SC 13G/A · Oct 28, 2024
- Polypid Ltd. SC 13G/A Filing — SC 13G/A · Oct 23, 2024
- PolyPid Enrolls Last Patient in SHIELD II Phase 3 Trial — 6-K · Oct 1, 2024
- PolyPid Ltd. Reports Q2 2024 Financials and Corporate Update — 6-K · Aug 14, 2024
- Polypid Ltd. SC 13G/A Filing — SC 13G/A · Aug 14, 2024
- PolyPid Ltd. Raises $3.8M in Private Placement — 6-K · Aug 2, 2024
- PolyPid Terminates Cantor Fitzgerald Sales Agreement — 6-K · Jul 19, 2024
- PolyPid Ltd. Holds Shareholder Meeting, Re-elects Accountants — 6-K · Jul 2, 2024
- PolyPid Ltd. Discusses SSI Unmet Need & SHIELD II Trial Update — 6-K · Jun 18, 2024
- PolyPid Ltd. Announces Shareholder Meeting for July 2 — 6-K · May 28, 2024
- PolyPid Ltd. Boosts Share Option Pool by 2M Shares — 6-K · May 17, 2024
- PolyPid Ltd. Reports Q1 2024 Financials and Corporate Update — 6-K · May 8, 2024
- PolyPid Enrolls 200th Patient in SHIELD II Phase 3 Trial — 6-K · Apr 30, 2024
- Polypid Ltd. SC 13G Filing — SC 13G · Apr 17, 2024
- Polypid Ltd. SC 13G Filing — SC 13G · Apr 5, 2024
- PolyPid Ltd. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 6, 2024
- Polypid Ltd. SC 13G Filing — SC 13G · Mar 1, 2024
- PolyPid Hits 100-Patient Milestone in SHIELD II Phase 3 Trial — 6-K · Feb 14, 2024
- PolyPid Raises $16.2M in Private Placement for SHIELD II Trial — 6-K · Jan 5, 2024